Week 1: Introduction and Fundamentals

by Aya Gonzalez

Sep 01, 2022


  • Introduction to the course 
  • Overview of Psychedelic-Assisted Therapy 
  • Brief history of psychedelic medicines 
  • Introduction to the Numinus care model

Learning Outcomes

  • Justify the prioritization of integrative and transformative mental wellness within the context of psychedelic-assisted therapy by contrasting it with conventional mental health treatment approaches.
  • Describe the seven guiding principles of psychedelic-assisted therapy which include embodiment, mindfulness, trauma- and violence-informed care, justice, equity, dignity, and inclusion (JEDI), Indigenous cultural safety and humility, harm reduction, and connection for the purposes of applying these to the delivery of care.
  • Describe the mission, vision, and values of Numinus.
  • Describe ethical considerations for psychedelic-assisted therapy that create unique vulnerabilities for persons seeking care.
  • Differentiate the outcomes of the psilocybin, MDMA, and Ketamine PAT from a high-level.
  • Briefly explain the structure of psychedelic-assisted therapy.
  • Explain the impact that The Controlled Drug and Substances Act (Canada) and The Controlled Substances Act (United States) had and continue to have on psychedelic research and drug policy.

We want to connect with you!

Sign up here so we can keep in touch.